Global Data: Women's Infertility - Pipeline Assessment and Market Forecasts
Global Data: Women's Infertility - Pipeline Assessment and Market Forecasts
GlobalData, the industry analysis specialist, has released its new report, "Women's Infertility - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global women's infertility therapeutics market. The report identifies the key trends shaping and driving the global women's infertility therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global women's infertility sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. GlobalData estimates that the global women's infertility market was valued at $1,417m in 2009 and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% to reach $1,609m by 2017. The slow market growth is attributed to the patent expiry of the branded products such as Cetrotide and Ovidrel in 2015. Some key branded products, such as Cetrotide, GONAL-f, Crinone, Ovidrel, Luveris, Pergoveris and Puregon, are going to face a severe threat from generics as they approach patent expiry between 2010 and 2015
For Sample Pages please click the link below
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Women's-Infertility-Pipeline-Assessment-and-Market-Forecasts-to-2017&Title=Pharmaceuticals_and_Healthcarehttp://www.globaldata.com/reportstore/Report.aspx?ID=Women's-Infertility-Pipeline-Assessment-and-Market-Forecasts-to-2017,Pharmaceuticals_and_Healthcare&ReportType=Industry_Report,Industry_Report
This report offers you:
* The scope of the report includes:
* Annualized global women's infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
* Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
* Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include Gonadotropin-Releasing hormone (GnRH) antagonists, AMP-activated protein kinase (AMPK) agonists, GnRH agonists, Recombinant human chorionic gonatropin, Follicle stimulating hormone, Selective Estrogen Receptor Modulators (SERMs) and aromatase inhibitor.
* Analysis of the current and future market competition in the global women's infertility therapeutics market. The key future market players covered are Ferring Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd. and PregLem SA and Merck.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the women's infertility market.
For More Information please click the link below
http://www.globaldata.com/reportstore/Report.aspx?ID=Women's-Infertility-Pipeline-Assessment-and-Market-Forecasts-to-2017&ReportType=Industry_Report&Title=Pharmaceuticals_and_Healthcarehttp://www.globaldata.com/reportstore/Report.aspx?ID=Women's-Infertility-Pipeline-Assessment-and-Market-Forecasts-to-2017&ReportType=Industry_Report&Title=Pharmaceuticals_and_Healthcare
About Company:
GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.
Visit our Report Store
http://www.globaldata.com/reportstore/
Global Data: Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts Global Data: Acne - Pipeline Assessment and Market Forecasts Global Data: Meningitis Preventive Vaccines - Pipeline Assessment and Market Forecasts Global Data: Neuropathic Pain - Pipeline Assessment and Market Forecasts Global Data: Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Global Data: Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts Global Data: Osteoporosis - Pipeline Assessment and Market Forecasts to 2017 Global Data: Stomach Cancer - Pipeline Assessment and Market Forecast to 2017 Wyless, leading the way in global M2M managed services PlacidWay Joins With the Medical Tourism Association to Promote Global Healthcare Global markets could tow a new line if the US Dollar loses its' safe haven status. Is this a real possibility? Getting ProFollica Free Shipping - What You Need To Know Things You Should Consider When Purchasing a Hot Tub